Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.
Azmi AS, Philip PA, Aboukameel A, Wang Z, Banerjee S, Zafar SF, Goustin AS, Almhanna K, Yang D, Sarkar FH, Mohammad RM.
Azmi AS, et al. Among authors: sarkar fh.
Curr Cancer Drug Targets. 2010 May;10(3):319-31. doi: 10.2174/156800910791190229.
Curr Cancer Drug Targets. 2010.
PMID: 20370686
Free PMC article.